Baseline asthma burden, comorbidities, and biomarkers in omalizumab-treated patients in PROSPERO

John J. Oppenheimer, Paul Allen Greenberger

Research output: Contribution to journalEditorial

4 Scopus citations
Original languageEnglish (US)
Pages (from-to)474-475
Number of pages2
JournalAnnals of Allergy, Asthma and Immunology
Volume119
Issue number6
DOIs
StatePublished - Dec 1 2017

ASJC Scopus subject areas

  • Immunology and Allergy
  • Pulmonary and Respiratory Medicine

Cite this